GSK Violated Competition Laws: EU Advocate General

Law360, New York (April 1, 2008, 12:00 AM EDT) -- The Court of Justice of the European Communities' advocate general has suggested that the court find GlaxoSmithKline Plc's practice of selling three drugs in Greece on a quota system in order to combat parallel trading a violation of Europe's competition laws.

The advocate general found Tuesday in a nonbinding, advisory opinion that Glaxo subsidiary GlaxoSmithKline AEVE was likely abusing its dominant market position.

In 2000, Glaxo switched from meeting orders from Greek wholesalers for the drugs to supplying drugs directly to hospitals and pharmacies through a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.